原发性脊髓H3 K27M突变型弥漫性中线胶质瘤的临床影像学特征
本研究纳入59例经病理证实的髓内星形细胞瘤患者,按H3 K27M免疫组化状态分组,比较突变型与野生型的临床影像学特征。仅症状持续时间与H3 K27M突变独立相关(OR 0.82,95%CI 0.68-0.94,p=0.016),突变型症状持续时间更短;MRI特征两组无显著差异,p53在突变型中常过表达;在组织学高级别星形细胞瘤中,突变不影响生存结局。
要点
- 症状持续时间短与髓内星形细胞瘤H3 K27M突变独立相关,OR 0.82。
- MRI特征在H3 K27M突变型与野生型间无显著差异,无法预测突变。
- 组织学高级别脊髓星形细胞瘤中H3 K27M突变未影响生存结局。
核心结论
- 症状持续时间与髓内星形细胞瘤H3 K27M突变相关,突变型症状持续时间更短。
- MRI特征异质,无影像特征能预测H3 K27M突变。
- H3 K27M突变在组织学高级别脊髓星形细胞瘤中未影响生存结局。
研究设计与样本
- 回顾性纳入59例经病理证实的髓内星形细胞瘤患者,按H3 K27M免疫组化状态分为突变组与野生型组,收集人口学、MRI及分子信息,行多因素logistic回归分析。
主要发现
- 仅症状持续时间与H3 K27M突变独立相关(OR 0.82,95%CI 0.68-0.94,p=0.016)。
- H3 K27M突变型患者症状持续时间短于野生型。
- MRI特征在突变型与野生型间无显著差异。
- H3 K27M突变型常见p53过表达。
- 组织学高级别星形细胞瘤中,突变型与野生型生存结局无统计学差异。
临床怎么用
- 对髓内星形细胞瘤患者,症状持续时间短提示需考虑H3 K27M突变可能。
- MRI特征无法可靠区分H3 K27M突变型与野生型,确诊依赖病理及分子检测。
- 组织学高级别脊髓星形细胞瘤中H3 K27M突变状态对生存预后影响不显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary spinal cord H3 K27M-mutant diffuse midline glioma (DMG) is a rare and devastating pathological entity. However, little attention has been paid to this disease. As a result, its clinicoradiological characteristics have yet to be described. The aim of this study was to describe the clinicoradiological characteristics of primary intramedullary H3 K27M-mutant DMG and to compare this tumor with the H3 K27 wild-type to explore potential features that could differentiate the two. METHODS: A total of 59 patients with pathologically confirmed intramedullary astrocytoma were included in this study. The cohort was divided into an H3 K27M-mutant group and H3 K27 wild-type group based on the status of H3 K27M according to an immunohistochemistry method. Demographic data, MRI features, and molecular information were collected. Multivariate logistic regression was conducted to investigate variables that might have a role in differentiating an H3 K27M DMG from an H3 K27 wild-type tumor. RESULTS: Only symptom duration showed an independent association with the H3 K27M mutation (OR 0.82, 95% CI 0.68-0.94, p = 0.016). Patients with spinal cord H3 K27M-mutant DMG had a shorter symptom duration than patients with H3 K27 wild-type glioma. No significant difference was found in terms of MRI features between the H3 K27M-mutant and H3 K27 wild-type groups. Additionally, H3 K27M-mutant DMG frequently demonstrated overexpression of p53. Survival outcome did not show a statistical difference between the H3 K27-mutant subgroup and H3 K27 wild-type subgroup in histologically high-grade astrocytoma. CONCLUSIONS: Symptom duration was associated with an H3 K27M mutation in intramedullary astrocytoma. MRI features were heterogeneous, and no imaging feature was able to predict the H3 K27M mutation. The H3 K27M mutation did not impact survival outcome in spinal histologically high-grade astrocytoma.
引用
- Cheng L, Wang L, Yao Q, et al. Clinicoradiological characteristics of primary spinal cord H3 K27M-mutant diffuse midline glioma. J Neurosurg Spine. 2021. PMID: 34560639. doi:10.3171/2021.4.SPINE2140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。